Novozymes A/S' B shares are listed on the
OMX Nordic exchange Copenhagen (OMX)
and are traded under the abbreviated name NZYM B and the ID code/ISIN DK0010272129.
The B shares are issued in units of DKK 10.
Index participation
The Novozymes share is member of the following major indices:
* OMX Nordic exchange Copenhagen's blue chips (OMXC20)
* OMX Nordic exchange Copenhagen's all share (KAX), free-float benchmark (KBX) and
15 / 1510 Materials (the latter in accordance with the MSCI classification)
* Bloomberg Europe and Bloomberg Consumer Europe
* Dow Jones STOXX, Dow Jones STOXX Nordic,
Dow Jones STOXX Healthcare and Dow Jones STOXX Pharmaceutical
* Dow Jones Sustainability Index STOXX and Dow Jones Sustainability Index World
* FTSE Intl. World Europe ex. UK, FTSE World Europe ex. UK Basic Industries and
FTSE World Europe ex. UK Chemicals
* FTSE4Good Europe and FTSE4Good Global
* MSCI Denmark Standard and MSCI Denmark Provisional
* Kempen/SNS Smaller Europe SRI Index and Nordic Sustainability Index
Share capital
According to the articles of association, Novozymes A/S has two share classes,
A shares and B shares.
|
Share capital
(DKK) |
No. of DKK 10 shares |
% shares |
| A shares |
107,487,200 |
10,748,720 |
16.5 |
| B shares |
542,512,800 |
54,251,280 |
83.5 |
| Total |
650,000,000 |
65,000,000 |
100.0 |
Each A share carries the right to cast one hundred votes at the company's
shareholders' meeting, each B share the right to cast ten votes.
|
|
No. of votes |
% votes |
|
A shares |
|
1,074,872,000 |
66.5 |
| B shares |
|
542,512,800 |
33.5 |
| Total |
|
1,617,384,800 |
100.0 |
The A share capital is held by Novo A/S, which is wholly owned by
the Novo Nordisk Foundation. In addition, Novo A/S holds 5,826,280 B shares,
which overall gives Novo A/S 25.5% of the total share capital and 70.1% of the votes.
Read more share information in the 2007 Annual Report, Accounts and Data (page 55).
Corporate governance
Read more about Novozymes' agenda on corporate governance.
(Last updated: 24/04/2008)